Form 4: Emergent BioSolutions Director Louis W. Sullivan Reports Acquisition of Stock and Options

Director Louis W. Sullivan reports acquisition of Emergent BioSolutions stock and options as part of annual grants for board service.

Summary

• On May 23, 2024, Louis W. Sullivan, a director of Emergent BioSolutions Inc., reported the acquisition of 17,430 shares of common stock and 25,748 stock options.
• These acquisitions are part of the annual grant of restricted stock units (RSUs) and stock options under the company's Stock Incentive Plan for Board and Committee service.
• The RSUs represent the right to receive one share of Emergent BioSolutions common stock upon vesting, and the stock options represent the right to purchase one share at an exercise price of $5.02.
• The shares underlying the RSUs and options will vest on the day prior to the one-year anniversary of the grant date, contingent upon Sullivan remaining a member of the Company's board of directors.
• Following the reported transaction, Sullivan beneficially owns 104,695 shares of common stock and 25,748 stock options.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction related to director compensation, indicating a neutral to slightly positive sentiment as it aligns director interests with company performance.

Positives

• The grant of RSUs and stock options aligns the director's interests with those of the shareholders.
• Continued board service is required for vesting, incentivizing ongoing commitment.

Future Outlook

The vesting of the RSUs and stock options is contingent upon the reporting person remaining a member of the Company's board of directors through the Annual Grant Vesting Date.

Industry Context

Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to investors.

Stakeholder Impact

• The acquisition of stock and options by a director can positively influence shareholder confidence by aligning management's interests with those of the shareholders.

Key Dates